This announcement is a separate document:
富祥药业：2022年半年业度绩预告
Fuxiang Pharmaceutical: Business performance forecast for the first half of 2022
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.